Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Stallard

Showing results (71-80 of 153) with videos related to

Pageof 16
Sort By:
Statistics in Medicine|March 23, 2012
Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methodsPeter K Kimani, Ekkehard Glimm, Willi Maurer, et al.
Patient Education and Counseling|February 14, 2015
The effects of a brief intervention to promote walking on Theory of Planned Behavior constructs: a cluster randomized controlled trial in general practiceStefanie L Williams, Susan Michie, Jeremy Dale, et al.
The American Journal of Tropical Medicine and Hygiene|November 6, 2007
Spatial analysis of risk factors for childhood morbidity in NigeriaNgianga-Bakwin Kandala, Chen Ji, Nigel Stallard, et al.
European Journal of Public Health|December 16, 2006
Socioeconomic risk, parenting during the preschool years and child health age 6 yearsJay Belsky, Brian Bell, Robert H Bradley, et al.
Journal of Biopharmaceutical Statistics|November 9, 2010
Comments on the draft guidance on "adaptive design clinical trials for drugs and biologics" of the U.S. Food and Drug AdministrationWerner Brannath, Hans Ulrich Burger, Ekkehard Glimm, et al.
Statistics in Medicine|January 8, 2025
EditorialRobert W Platt, Nigel Stallard, Lisa McShane, et al.
Statistics in Medicine|December 16, 2011
A hybrid procedure for detecting global treatment effects in multivariate clinical trials: theory and applications to fMRI studiesGiorgos Minas, Fabio Rigat, Thomas E Nichols, et al.
Trials|January 16, 2020
Bayesian group sequential designs for phase III emergency medicine trials: a case study using the PARAMEDIC2 trialElizabeth G Ryan, Nigel Stallard, Ranjit Lall, et al.
Journal of Biopharmaceutical Statistics|September 18, 2015
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic reviewThomas Ondra, Alex Dmitrienko, Tim Friede, et al.
Biometrical Journal. Biometrische Zeitschrift|March 22, 2017
Dose-finding methods for Phase I clinical trials using pharmacokinetics in small populationsMoreno Ursino, Sarah Zohar, Frederike Lentz, et al.
Pageof 16

Showing results (71-80 of 153) with videos related to

Sort By:
Pageof 16
Statistics in Medicine|March 23, 2012
Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methodsPeter K Kimani, Ekkehard Glimm, Willi Maurer, et al.
Patient Education and Counseling|February 14, 2015
The effects of a brief intervention to promote walking on Theory of Planned Behavior constructs: a cluster randomized controlled trial in general practiceStefanie L Williams, Susan Michie, Jeremy Dale, et al.
The American Journal of Tropical Medicine and Hygiene|November 6, 2007
Spatial analysis of risk factors for childhood morbidity in NigeriaNgianga-Bakwin Kandala, Chen Ji, Nigel Stallard, et al.
European Journal of Public Health|December 16, 2006
Socioeconomic risk, parenting during the preschool years and child health age 6 yearsJay Belsky, Brian Bell, Robert H Bradley, et al.
Journal of Biopharmaceutical Statistics|November 9, 2010
Comments on the draft guidance on "adaptive design clinical trials for drugs and biologics" of the U.S. Food and Drug AdministrationWerner Brannath, Hans Ulrich Burger, Ekkehard Glimm, et al.
Statistics in Medicine|January 8, 2025
EditorialRobert W Platt, Nigel Stallard, Lisa McShane, et al.
Statistics in Medicine|December 16, 2011
A hybrid procedure for detecting global treatment effects in multivariate clinical trials: theory and applications to fMRI studiesGiorgos Minas, Fabio Rigat, Thomas E Nichols, et al.
Trials|January 16, 2020
Bayesian group sequential designs for phase III emergency medicine trials: a case study using the PARAMEDIC2 trialElizabeth G Ryan, Nigel Stallard, Ranjit Lall, et al.
Journal of Biopharmaceutical Statistics|September 18, 2015
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic reviewThomas Ondra, Alex Dmitrienko, Tim Friede, et al.
Biometrical Journal. Biometrische Zeitschrift|March 22, 2017
Dose-finding methods for Phase I clinical trials using pharmacokinetics in small populationsMoreno Ursino, Sarah Zohar, Frederike Lentz, et al.
Pageof 16